Results for tag: "Probuphine"

Probuphine is a medication used to treat opioid addiction disorders. It is a subdermal implant that is inserted under the skin and releases a steady dose of buprenorphine, an opioid partial agonist, over a period of six months. Probuphine is designed to reduce cravings and withdrawal symptoms associated with opioid addiction, and to help patients maintain abstinence from opioid use. It is intended to be used in combination with counseling and other forms of psychosocial support. Probuphine is manufactured by Titan Pharmaceuticals, Inc. and marketed by Braeburn Pharmaceuticals, Inc. in the United States. It is also available in Canada, Australia, and several European countries. Other companies involved in the Probuphine market include Indivior, Reckitt Benckiser, and Mallinckrodt Pharmaceuticals. Show Less Read more